Abstract
-
ISH is diagnosed when systolic blood pressure is more than 140 mmHg with a normal or low diastolic pressure (less than 90 mmHg).
-
Prevalence of ISH increases with age, and it is one of the special problems in hypertension among geriatric population.
-
Contrary to traditional thinking, systolic hypertension is a strong predictor of cardiovascular morbidity and mortality.
-
Increased arterial stiffness resulting in augmented reflection of the pulse wave is the major pathophysiological mechanism in ISH along with functional changes like endothelial dysfunction, enhanced sympathetic tone, and abnormal sodium hemostasis.
-
Management of ISH can be a challenge, and drugs which reduce the augmentation index play a pivotal role in refractory cases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fletcher AE, Bulpitt CJ. Isolated systolic hypertension in the elderly. Cardiovasc Risk Factors. 1992;2:133–9.
Whelton PK, Jiang HE, Klag MJ. Blood pressure in westernized populations. In: Swales JD, editor. Textbook of hypertension. Blackwell Scientific Publications: London; 1994. p. 11–21.
Khder Y, Des Boscs LB, Aliot E, Zannad F. Endothelial, viscoelastic and sympathetic factors contributing to the arterial wall changes during ageing. Cardiol Elder. 1996;4:161–5.
Salvetti A, Ghaidoni L, Gennari A, Taddei S. Age influence on some aspects of cardiovascular adaptation to hypertension. High Blood Pressure. 1995;4:87–96.
Vanhoutte PM. Aging and vascular responsiveness. J Cardiovasc Pharmacol. 1988;12(Suppl 8):S11–8.
Fantini F, et al. Parallel increase in carotid, brachial and left ventricular cross-sectional areas in arterial hypertension. J Hum Hypertens. 1997;11:515–21.
Gariepy J, et al. Echographic assessment of carotid and femoral arterial structure in men with essential hypertension. Am J Hypertens. 1996;9:126–36.
O’Rourke MF, Kelly RP. Wave reflection in the systemic circulation and its implications in ventricular function. J Hypertens. 1993;11:327–37.
Schiffrin EL. Vascular stiffening and arterial compliance. Implications for systolic blood pressure. Am J Hypertens. 2004;17:39S–48.
Society of Actuaries. Build and Blood pressure study, vol. 1. Chicago: Society of Actuaries; 1959. p. 268.
Wilkinson IB, Hall IR, MacCallum H, et al. Pulse-wave analysis. Clinical evaluation of a non-invasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol. 2002;22:147–52.
Cohn JN. Vascular wall function as a risk marker for cardiovascular disease. J Hypertens. 1999;17(Suppl 5):S41–4.
Stokes GS. Nitrates as adjunct hypertensive treatment. Curr Hypertens Rep. 2006;8:60–8.
Stokes GS, Barin ES, Gilfillan KL. Effects of isosorbide mononitrate and AII inhibition on pulse wave reflection in hypertension. Hypertension. 2003;41:297–301.
Weinberger MH, Miller JZ, Luft FC, et al. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension. 1986;8:127–34.
Bagrov AY, Lakatta EG. The dietary sodium-blood pressure plot “stiffens”. Hypertension. 2004;44:22–4.
Silagy CA, McNeil JJ. Epidemiologic aspects of isolated systolic hypertension and implications for future research. Am J Cardiol. 1992;69:213–8.
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413–46.
Rowe JW, Troen BR. Sympathetic nervous system and aging in man. Endocr Rev. 1980;12:167–79.
WHO/ISH Guidelines Subcommittee. 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. J Hypertens. 1993;11:905–18.
Multiple Risk Factor Intervention Trial. Risk factor changes and mortality results. JAMA. 1982;248:1465–77.
Curb JD, et al. Isolated systolic hypertension in 14 communities. Am J Epidemiol. 1985;121:362–70.
Kannel WB, Dawber TR, McGee DL. Perspectives on systolic hypertension. The Framingham Study. Circulation. 1980;61:1179–82.
Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22:312–8.
Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. Br Med J. 1992;304:405–12.
SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA. 1991;265:3255–64.
Staessen J, Amery A, Fagard R. Isolated systolic hypertension in the elderly. J Hypertens. 1990;8:393–405.
Townsend MS, Fulgoni VL III, Stern JS, et al. Low mineral intake is associated with high systolic blood pressure in the Third and Fourth National Health and Nutrition Examination Surveys. Could we all be right? Am J Hypertens. 2005;18:261–9.
He FJ, Markandu ND, MacGregor GA. Modest salt reduction lowers blood pressure in isolated systolic hypertension and combined hypertension. Hypertension. 2005;46:66–70.
Gates PE, Tanaka H, Hiatt WR, Seals DR. Dietary sodium restriction rapidly improves large elastic artery compliance in older adults with systolic hypertension. Hypertension. 2004;44:35–41.
Brennan P, Pescatello LS, Bohannon RW, et al. Time spent moving is related to systolic blood pressure among older women. Prev Cardiol. 2005;8:160–4.
Ferrier KE, Waddell TK, Gatzka CD, et al. Aerobic exercise training does not modify large-artery compliance in isolated systolic hypertension. Hypertension. 2001;38:222–6.
Chen C-H, Ting C-T, Lin S-J, et al. Different effects of fosinopril and atenolol on wave reflections in hypertensive patients. Hypertension. 1995;25:1034–41.
TO M, Lauri J, Bertram D, Anderson A. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens. 2004;17:118–23.
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA. 2002;288:2981–97.
London G, Schmieder R, Calvo C, Asmar R. IndapamideSR versus candesartan and amlodipine in hypertension: the X-CELLENT Study. Am J Hypertens. 2006;19:113–21.
Kostis JB, Wilson AC, Freudenberger RS, et al. Long term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. SHEP Collaborative Research Group. Am J Cardiol. 2005;95:29–35.
Turnbull F, Blood Pressure Treatment Trialists’ Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively designed overviews of randomized trials. Lancet. 2003;362:1527–153.
Kjeldsen SE, Lyle PA, Kizer JR, et al. The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study. J Clin Hypertens. 2005;7:152–8.
Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366:895–906.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 The Editor(s)
About this chapter
Cite this chapter
Divakara Menon, S.M. (2018). Isolated Systolic Hypertension. In: Nair, B. (eds) Geriatric Medicine. Springer, Singapore. https://doi.org/10.1007/978-981-10-3253-0_16
Download citation
DOI: https://doi.org/10.1007/978-981-10-3253-0_16
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-3252-3
Online ISBN: 978-981-10-3253-0
eBook Packages: MedicineMedicine (R0)